These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11264051)

  • 1. Resolution of chronic parvovirus b19-induced anemia, by use of highly active antiretroviral therapy, in a patient with acquired immunodeficiency syndrome.
    Ware AJ; Moore T
    Clin Infect Dis; 2001 Apr; 32(7):E122-3. PubMed ID: 11264051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapy.
    Chen MY; Hung CC; Fang CT; Hsieh SM
    Clin Infect Dis; 2001 May; 32(9):1361-5. PubMed ID: 11303273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parvovirus B19 encephalitis presenting as immune restoration disease after highly active antiretroviral therapy for human immunodeficiency virus infection.
    Nolan RC; Chidlow G; French MA
    Clin Infect Dis; 2003 May; 36(9):1191-4. PubMed ID: 12715316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy.
    Intalapaporn P; Poovorawan Y; Suankratay C
    J Infect; 2006 Aug; 53(2):e79-82. PubMed ID: 16313965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study.
    LaMonte AC; Paul ME; Read JS; Frederick MM; Erdman DD; Han LL; Anderson LJ;
    J Infect Dis; 2004 Mar; 189(5):847-51. PubMed ID: 14976602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Persistent parvovirus B19 infection in a patient with AIDS].
    García-Tapia AM; Fernández C; Bascuñana A
    Enferm Infecc Microbiol Clin; 1993 Feb; 11(2):107-8. PubMed ID: 8386943
    [No Abstract]   [Full Text] [Related]  

  • 7. Parvovirus b19 infection in HIV patient with pure red cell aplasia.
    Sanphasitvong W; Poovorawan K; Boonsuk P; Assanasen T; Na Nakorn T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1216-20. PubMed ID: 16438148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of anemia induced by parvovirus B19 in a patient with AIDS after combined antiretroviral therapy.
    Scapellato PG; Palumbo AM; Del Valle S
    Mayo Clin Proc; 2000 Feb; 75(2):215-6. PubMed ID: 10683664
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
    Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K
    Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on "Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy" by Intalapaporn et al.
    Koduri PR
    J Infect; 2007 Jul; 55(1):90-1. PubMed ID: 17083979
    [No Abstract]   [Full Text] [Related]  

  • 11. Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine.
    Ferrer E; Podzamczer D; Arnedo M; Fumero E; McKenna P; Rinehart A; Pérez JL; Barberá MJ; Pumarola T; Gatell JM; Gudiol F;
    J Infect Dis; 2003 Feb; 187(4):687-90. PubMed ID: 12599088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy.
    Jiménez-Expósito MJ; Alonso-Villaverde C; Sardà P; Masana L
    AIDS; 1999 Jan; 13(1):152-3. PubMed ID: 10207569
    [No Abstract]   [Full Text] [Related]  

  • 13. Withdrawal of Mycobacterium avium complex suppressive therapy in HIV-1-infected patients on highly active antiretroviral therapy.
    Martínez E; Miró JM; González J; Mallolas J; Gatell JM
    AIDS; 1999 Jan; 13(1):147-8. PubMed ID: 10207565
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic drift of parvovirus B19 is found in AIDS patients with persistent B19 infection.
    Hung CC; Sheng WH; Lee KL; Yang SJ; Chen MY
    J Med Virol; 2006 Nov; 78(11):1374-84. PubMed ID: 16998895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in B19 viral load prior to relapse of anaemia in an AIDS patient with persistent B19 infection.
    Hung CC; Lee KL; Chen MY
    J Infect; 2001 Aug; 43(2):150-2. PubMed ID: 11676524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial transient red cell aplasia from parvovirus B-19 infection].
    Salvini F; Tonella M; Carpani G; Scaglioni S; Zuccotti GV
    Pediatr Med Chir; 2002; 24(4):306-7. PubMed ID: 12197091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
    Podzamczer D; Ferrer E; Consiglio E; Gatell JM; Perez P; Perez JL; Luna E; González A; Pedrol E; Lozano L; Ocaña I; Llibre JM; Casiró A; Aranda M; Barrufet P; Martínez-Lacasa J; Miró JM; Badía X; Casado A; Lupo S; Cahn P; Maños M; Estela J
    Antivir Ther; 2002 Jun; 7(2):81-90. PubMed ID: 12212928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
    Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
    J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy.
    De Luca A; Ammassari A; Cingolani A; Giancola ML; Antinori A
    AIDS; 1998 Oct; 12(14):1937-8. PubMed ID: 9792402
    [No Abstract]   [Full Text] [Related]  

  • 20. Considerations on the effectiveness of nevirapine in protease inhibitor-based regimen simplification.
    Martínez E; Gatell JM
    AIDS; 2007 Aug; 21(13):1829-30. PubMed ID: 17690588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.